tiprankstipranks

Christopher Missling Insider Profile

4 Followers
Christopher Missling, CFO at ImmunoGen, holds 0.00 shares in ImmunoGen (Ticker: IMGN), holds 1.25M shares in Anavex Life Sciences (Ticker: AVXL). Most recently, Christopher Missling ― shares of ImmunoGen on ― for an estimated value of ―.
tipranks
Christopher Missling

Christopher Missling
ImmunoGen (IMGN)
CFO

Ranked #30,621 out of 99,797 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+14.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$11M
100.00%
A breakdown of Christopher Missling's holdings

Insider Roles

Anavex Life Sciences
(AVXL)
President & CEO, Director
Roles that Christopher Missling holds in companies

Most Profitable Insider Trade

Stock:
Anavex Life Sciences
(AVXL)
Rating:Informative Sell
Date:Jul 01, 2021 - Jul 01, 2022
Return:+58.00%
The most profitable trade made by Christopher Missling

Christopher Missling's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IMGN
ImmunoGen
$0.00
Anavex Life Sciences
Apr 01, 2024
President & CEO, Director
Uninformative Buy
96.86K
$10.79M
List of latest transactions for each holding click on a transaction to see Christopher Missling's performance on stock

Christopher Missling insider profile FAQ

What is the percentage of profitable transactions made by Christopher Missling?
The percentage of profitable transactions made by Christopher Missling is 67%.
    What is the average return per transaction made by Christopher Missling?
    The average return per transaction made by Christopher Missling is 14.60%.
      What stocks does Christopher Missling hold?
      Christopher Missling holds: IMGN, AVXL stocks.
        What was Christopher Missling’s latest transaction?
        Christopher Missling latest transaction was an Uninformative Buy of ―.
          What was Christopher Missling's most profitable transaction?
          Christopher Missling’s most profitable transaction was an Informative Sell of AVXL stock on July 1, 2021. The return on the trade was 58.00%.
            What is Christopher Missling's role in ImmunoGen?
            Christopher Missling's role in ImmunoGen is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.